mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |